Creating reliable pharmaceutical distribution networks and supply chains in African countries: Implications for access to medicines

Research in Social and Administrative Pharmacy

Volumn 5, Issue 3, 2009, Pages 286-297

  Tetteh, Ebenezer ^a  

^a NONE

Author keywords

Africa; Drug regulation; Pharmaceutical distribution; Quality assurance

Indexed keywords

EID: 69449089116     PISSN: 15517411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sapharm.2008.08.001     Document Type: Note

References (29)

1. Money v mosquito: will an ambitious plan to subsidize antimalarial pills work?. November 3rd-9th issue. Economist 385 8553 (2007) 98
2. RBM AMFm. (2007). Affordable Medicines Facility-malaria: technical design. Available at: http://rbm.who.int/partnership/tf/globalsubsidy/AMFmTechProposal.pdf. Accessed 03.01.08.
3. Tetteh E.K. Providing affordable essential medicines to African households: the missing policies and institutions for price containment. Soc Sci Med 66 3 (2008) 569-581
4. World Bank. (1994). Importance of pharmaceuti ls and essential drugprograms in Better Health for Africa: experience and lessons learned. Available at: www.worldbank.org Accessed 16.09.06.
5. Enemark, U., Alban, A. and Vasquez, E.C.S. (2004). Purchasing pharmaceuticals. World Bank HNP discussion paper. Available at: www.worldbank.org Accessed 16.09.06.
6. Guimier J.M., Candau D., Garenne M., and Teulieres L. Why drug prices are high in sub-Saharan Africa. Analysis of price structure: the case of Senegal. Santé 15 1 (2005) 41-52
7. WHO. World medicines situation. WHO/EDM/PAR/2004.5; 2004.
8. Taylor D., Mrazek M., and Mossialos E. Regulating pharmaceutical distribution and retail pharmacy in Europe. In: Mossialos E., Mrazek M., and Walley T. (Eds). Regulating Pharmaceuticals in Europe: Striving for Efficiency, Equity and Quality (2004), Open University Press, Maidenhead 196-212
9. Kaiser Family Foundation. (2005). Follow the pill: understanding the US commercial pharmaceutical supply chain. Available at: www.kff.org Accessed 18.04.06.
10. Maiga F.I., Haddad S., Fournier P., and Gauvin L. Public and private sector responses to essential drugs: a multilevel analysis of drug prescription and selling practices in Mali. Soc Sci Med 57 5 (2003) 937-948
11. Quick J.D., Boohene N.A., Rankin J., and Mbwasi R.J. Medicines supply in Africa: should improve through regional collaborations and accredited drug shops. Br Med J 331 (2005) 709-710
12. Rahman S., and Smith D.K. Use of location allocation models in health services development in developing nations. Eur J Oper Res 123 3 (2000) 37-452
13. Reekie W.D. Cartels, spontaneous price discrimination and international pharmaceutical retailing. Int J Econ Bus 4 3 (1997) 279-285
14. Danzon P.M. Competition in the off-patent sector: the US experience. Pharma Pricing Rev 3 3 (1998) 46-50
15. Sanley, D., Abdallah, H., Rao, R., Azeez, J. and Garshong, B. (2003). Ghana Pharmaceutical Pricing Study: Policy Analysis and Recommendations. VA: DELIVER. Available at: www.deliver.jsi.com Accessed 08.02.07.
16. Huff-Rousselle, M. and Sangeeta, R. (2002). Ghana: Estimating the Cost Logistics in the Ministry of Health Supply System. VA: DELIVER. Available at: www.deliver.jsi.com Accessed 08.02.07.
17. Brumburgh, S. and Sangeeta, R. (2001). Process Mapping: First Step to Reengineering the Health Supply Chain of the Public Sector System. (VA: DELIVER). Available at: www.deliver.jsi.com Accessed 08.02.07.
18. Alix, B., Quesada, N., Abramson, N., Sanchez, A. and Olson, N. Decentralizing and Integrating Contraceptives Logistics in Latin America and the Caribbean, with Lessons Learned from Asia and Africa. VA: DELIVER for the US Agency for International Development. 2006. Available at: www.deliver.jsi.com Accessed 18.08.07.
19. Bossert T.J., Bomer D.M., and Amenyah J.K. Is decentralization good for the logistics system? Evidence on essential medicines logistics in Ghana and Guatemala. Health Policy Plan 22 2 (2007) 73-82
20. Summers R.S., Moller H., Meyer D., and Botha R. "Contracting-Out" Drug Procurement and Distribution: Experience with a Primary-Distributor System in South Africa. Essential Drugs Monitor issue No. 25 & 26 (1998), WHO, Geneva pp. 10-11
21. US General Accounting Office. Pharmacy Benefit Program: FEHBP Plans Satisfied with Savings and Services but Retail Pharmacies have Concerns (1997), GAO/HEHS-97-47, Washington, DC
22. Kloos H., Chama T., Abemo D., Tsadik K.G., and Belay S. Utilization of pharmacies and pharmaceutical drugs in Addis Ababa, Ethiopia. Soc Sci Med 22 6 (1986) 653-672
23. Hukins G., and Boyce D. Containing medicines costs in the private sector-the example of a medical benefit scheme. S Afr Med J 78 3 (1990) 152-154
24. Reekie, W.D. (2000). South Africa's battle with HIV/AIDS anddrug prices. National Centre for Policy Analysis No. 334 Available at: www.ncpa.org/∼ncpa/ba/ba334/ba334.pdf. Accessed 19.11.07.
25. WHO. Effective medicines regulation: ensuring safety, efficacy and quality. WHO/EDM/PAR/2003.2; 2003.
26. Kaplan W.A., and Laing R. Paying for pharmaceutical registration in developing countries. Health Policy Plan 18 3 (2003) 237-348
27. WHO. Pharmacovigilance: ensuring the safe use of medicines. WHO/EDM/2002.8; 2002a.
28. WHO. Traditional medicines: growing needs and potential. WHO/EDM/2002.4; 2002b.
29. Berman, P. and Bossert, T.J. (2000). A decade of health sectorreform in developing countries: what have we learned? Available at: www.hsph.harvard.edu/ihsg/publications. Accessed 19.08.06.